JP2007070291A - Sunscreen external lotion - Google Patents
Sunscreen external lotion Download PDFInfo
- Publication number
- JP2007070291A JP2007070291A JP2005259538A JP2005259538A JP2007070291A JP 2007070291 A JP2007070291 A JP 2007070291A JP 2005259538 A JP2005259538 A JP 2005259538A JP 2005259538 A JP2005259538 A JP 2005259538A JP 2007070291 A JP2007070291 A JP 2007070291A
- Authority
- JP
- Japan
- Prior art keywords
- ultraviolet light
- absorbing agent
- acid
- based ultraviolet
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
本発明は、抗酸化剤あるいは紫外線防御剤に併せて日焼け止め剤としてバジル抽出液を含有することで優れた日焼け防止効果を有する化粧品、外用医薬品等の皮膚外用剤に関する。 The present invention relates to an external preparation for skin, such as cosmetics and external medicines, which have an excellent sun protection effect by containing a basil extract as a sunscreen in combination with an antioxidant or an ultraviolet protective agent.
これまで、日焼け止め化粧料は主として紫外線吸収剤あるいは紫外線散乱剤を配合することで日焼けを防止してきた。しかしながら、紫外線吸収剤の多くは皮膚刺激性を有し、その配合量は制限される。紫外線散乱剤の多くは白色顔料であり、配合しすぎると化粧が厚くなる、白っぽくなりすぎるなど、やはりその配合量はある程度制限される。したがって、紫外線吸収あるいは紫外線散乱とは異なる方法で日焼けを防止する方法が求められていた。 So far, sunscreen cosmetics have been mainly prevented from sunburn by blending UV absorbers or UV scattering agents. However, many of the ultraviolet absorbers have skin irritation, and the blending amount thereof is limited. Many of the ultraviolet light scattering agents are white pigments. If they are added too much, the makeup becomes too thick, whitish, etc., so that the amount of addition is limited to some extent. Therefore, a method for preventing sunburn by a method different from ultraviolet absorption or ultraviolet scattering has been demanded.
バジルあるいは紫蘇科植物に関しては、その抗酸化作用についての報告(非特許文献1-3)および活性酸素抑制剤としての特許(特許文献1)あるいは美白に関するもの(特許文献2-3)、アトピー性皮膚炎治療・予防剤に関するもの(特許文献4)、消臭に関するもの(特許文献5-6)、抗老化防御剤に関するもの(特許文献7)などがこれまでにあるが、日焼け止め剤でバジルを有効成分とするもの、特に抗酸化剤あるいは紫外線吸収剤との併用により大きな効果を得たものについての報告はない。
そこで、紫外線吸収剤、紫外線散乱剤とは違う、紫外線による日焼けを防止する効果を有する物質を併せて含有させることで、相乗的に優れた日焼け防止作用を有する皮膚外用剤を提供することを課題とした。 Therefore, it is a problem to provide a skin external preparation having a synergistically excellent sun protection effect by containing a substance having an effect of preventing sunburn due to ultraviolet rays, which is different from an ultraviolet absorber and an ultraviolet scattering agent. It was.
紫外線による紅斑が活性酸素種の生成を介して形成されるという機構に着目し、紫外線が皮膚で紅斑をおこすのを防ぐ物質のスクリーニングを行なった。その結果、生理的に抗酸化作用を示すビタミンCに加えて、バジル抽出液に紫外線による紅斑形成を強く抑制する効果を見出した。さらに、ビタミンCなどの抗酸化剤あるいは紫外線防御剤などと併用することで、バジル抽出液がより大きな効果を示すことを見出し、本発明を完成するに至った。 Focusing on the mechanism that ultraviolet erythema is formed through the generation of reactive oxygen species, we screened for substances that prevent ultraviolet rays from causing erythema on the skin. As a result, in addition to vitamin C, which exhibits physiological antioxidant activity, the basil extract was found to have an effect of strongly suppressing erythema formation due to ultraviolet rays. Furthermore, the present inventors have found that the basil extract exhibits a greater effect when used in combination with an antioxidant such as vitamin C or an ultraviolet protective agent, and thus completed the present invention.
抗酸化剤に併せてバジル抽出液を配合することでより優れた皮膚外用剤を提供できる。また、バジル抽出液の安全性の高さから、ビタミンCなどの安全性の高い抗酸化剤と併用することで高い効果を持ち、直接皮膚に適用しても安全である皮膚外用剤を提供できる。 A more excellent external preparation for skin can be provided by blending a basil extract together with an antioxidant. In addition, because of the high safety of basil extract, it can be used in combination with highly safe antioxidants such as vitamin C, and can provide a skin external preparation that is safe even when applied directly to the skin. .
紫外線防御剤に併せてバジル抽出液を配合することで、より優れた皮膚外用剤を提供できる。また、バジル抽出液を併せて配合することで従来より少ない配合量の紫外線吸収剤で同程度の日焼け防止効果が得られ、より安全な皮膚外用剤を提供できる。 A more excellent external preparation for skin can be provided by blending a basil extract together with a UV protection agent. Further, by blending the basil extract together, the same amount of sunscreen prevention effect can be obtained with an ultraviolet absorber having a smaller blending amount than before, and a safer skin external preparation can be provided.
本発明に用いることができるバジル抽出液はシソ科(Labiatae)メボウキ属バジル(Ocimum basilicum )全草を乾燥させたものから、水などの溶媒により抽出して得られるもので、その溶媒、抽出方法に特に制限はない。又、併せて用いる抗酸化剤及び紫外線吸収剤も、市販されているものであれば特に制限は無い。 The basil extract that can be used in the present invention is obtained by extracting a whole plant of Labiatae genus basil (Ocimum basilicum) with a solvent such as water. There are no particular restrictions. Moreover, if the antioxidant and ultraviolet absorber used together are also marketed, there will be no restriction | limiting in particular.
本発明におけるバジル抽出液の含有量は好ましくは0.5%〜10%の範囲である。ビタミン系抗酸化剤、例えばビタミンC及びその誘導体並びにその塩、ビタミンE類及びそれらの誘導体並びにそれらの塩の含有量は、好ましくは0.5%〜5%の範囲であり、合成系の抗酸化剤、例えばジブチルヒドロキシトルエン及びブチルヒドロキシアニソールの含有量は、好ましくは0.5%〜2%の範囲である。 The content of the basil extract in the present invention is preferably in the range of 0.5% to 10%. The content of vitamin antioxidants such as vitamin C and derivatives thereof and salts thereof, vitamin Es and derivatives thereof and salts thereof is preferably in the range of 0.5% to 5%, and synthetic antioxidants For example, the content of dibutylhydroxytoluene and butylhydroxyanisole is preferably in the range of 0.5% to 2%.
ケイ皮酸系紫外線吸収剤、例えばパラメトキシケイ皮酸-2-エチルヘキシル、パラメトキシケイ皮酸イソプロピル、パラメトキシハイドロケイ皮酸ジエタノールアミン塩、ジパラメトキシケイ皮酸-モノ-2-エチルヘキサン酸グリセリル、メトキシケイ皮酸オクチルの含有量は、好ましくは0.5%〜10%の範囲であり、ベンゾフェノン系紫外線吸収剤、例えば2-ヒドロキシ-4-メトキシベンゾフェノン、2,4-ジヒドロキシベンゾフェノンの含有量は好ましくは0.5%〜5%の範囲であり、安息香酸系紫外線吸収剤、パラアミノ安息香酸、パラアミノ安息香酸エステル、パラアミノ安息香酸グリセリルの含有量は、好ましくは0.5%〜5%の範囲であり、サリチル酸系紫外線吸収剤、例えばサリチル酸メチル、サリチル酸-2-エチルヘキシル、サリチル酸ジプロピレングリコール、サリチル酸アミル、サリチル酸ベンジルの含有量は、好ましくは0.5%〜10%の範囲であり、ジベンゾイルメタン系紫外線吸収剤、例えば4-t-ブチル-4’-メトキシベンゾイルメタンの含有量は、好ましくは0.5%〜5%の範囲であり、アントラニル酸系紫外線吸収剤、例えばメンチル-o-アミノベンゾエート、3-ジフェニルアクリレート、アントラニル酸メンチルの含有量は、好ましくは0.5%〜5%の範囲である。紫外線散乱剤、例えば酸化チタン、酸化亜鉛、酸化セリウム、酸化ジルコニウムの含有量は、好ましくは1%〜30%の範囲である。これらの範囲でバシル抽出液と抗酸化剤あるいは紫外線防御剤を併せて配合すると、より優れた相乗的な日焼け防止効果が得られる。又、各含有量が上記範囲内であり、バシル抽出液との併用であれば、他の抗酸化剤あるいは紫外線防御剤の組み合わせは限定されるものではない。 Cinnamic acid UV absorbers such as paramethoxycinnamic acid-2-ethylhexyl, isopropyl paramethoxycinnamic acid, paramethoxyhydrocinnamic acid diethanolamine, diparamethoxycinnamic acid-glyceryl mono-2-ethylhexanoate The content of octyl methoxycinnamate is preferably in the range of 0.5% to 10%, and the content of benzophenone-based ultraviolet absorbers such as 2-hydroxy-4-methoxybenzophenone and 2,4-dihydroxybenzophenone is preferred. Is in the range of 0.5% to 5%, the content of benzoic acid UV absorber, paraaminobenzoic acid, paraaminobenzoic acid ester, glyceryl paraaminobenzoate is preferably in the range of 0.5% to 5%, salicylic acid type UV absorbers, such as methyl salicylate, 2-ethylhexyl salicylate, dipropylene glycol salicylate The content of ruthenium, amyl salicylate, and benzyl salicylate is preferably in the range of 0.5% to 10%, and the content of dibenzoylmethane-based UV absorbers, such as 4-t-butyl-4'-methoxybenzoylmethane, Preferably, it is in the range of 0.5% to 5%, and the content of anthranilic acid-based UV absorbers such as menthyl-o-aminobenzoate, 3-diphenyl acrylate, menthyl anthranilate is preferably in the range of 0.5% to 5%. is there. The content of the ultraviolet scattering agent such as titanium oxide, zinc oxide, cerium oxide or zirconium oxide is preferably in the range of 1% to 30%. When a basil extract and an antioxidant or UV protection agent are combined in these ranges, a more excellent synergistic sun protection effect can be obtained. Moreover, each content is in the said range, and if it is combined use with a basil extract, the combination of another antioxidant or a ultraviolet protective agent will not be limited.
以下、実施例を挙げて、本発明を具体的に説明するが、本発明は何ら実施例に限局されるものではない。 EXAMPLES Hereinafter, although an Example is given and this invention is demonstrated concretely, this invention is not limited to an Example at all.
シソ科(Labiatae)メボウキ属バジル(Ocimum
basilicum )全草を乾燥させ、その200gを60℃の水2リットルに4時間浸漬し、ろ過してバジル水抽出液を得た。
Labiatae (Ocimum)
Basilicum) was dried, and 200 g of the whole plant was soaked in 2 liters of water at 60 ° C. for 4 hours and filtered to obtain a basil water extract.
(試験例)
表1に示す処方でクリームを調製し、日焼け防止効果を次の方法で調べた。
(Test example)
Creams were prepared according to the formulation shown in Table 1, and the sun protection effect was examined by the following method.
水溶性成分および精製水を混合し、これを水相とした。油溶性成分を混合し、これを油相とした。水相、油相とも80℃に加熱して溶解し、水相に油相を攪拌しながらゆっくりと加えて乳化し、37℃まで攪拌しながら冷却し、クリームを得た。 A water-soluble component and purified water were mixed to form an aqueous phase. An oil-soluble component was mixed to obtain an oil phase. Both the aqueous phase and the oil phase were dissolved by heating to 80 ° C., and the oil phase was slowly added to the aqueous phase with stirring to emulsify, and the mixture was cooled to 37 ° C. with stirring to obtain a cream.
(試験方法)
Hartley系モルモットにおいて紅斑形成に必要な最小紫外線用量(MED)を測定し、MEDを増加させる能力を測定することにより日焼け防止効果を評価した。剃毛した背腹部に紫外線照射装置(Dermaray
M-DMR 50, 紫外線ランプ[東芝FL20S.E-30/DMR, 7灯]、東芝医療用品)を用いて紫外線を照射し、照射時間ごとに紅斑の有無を観察することでMEDを測定した。紫外線強度計(UVR-305/365,
東芝医療用品)で測定し、照射強度は 2.080 mW/cm2で1分間の照射エネルギーは1.25×106erg/cm2/minであった。各クリームは紫外線を照射する30分前に塗布した。
(Test method)
The sun protection effect was evaluated by measuring the minimum ultraviolet dose (MED) required for erythema formation in Hartley guinea pigs and measuring the ability to increase MED. UV irradiation device (Dermaray on shaved back abdomen
MED was measured by irradiating with UV light using M-DMR 50, UV lamp [Toshiba FL20S.E-30 / DMR, 7 lights], Toshiba medical supplies) and observing the presence or absence of erythema at each irradiation time. UV intensity meter (UVR-305 / 365,
The intensity of irradiation was 2.080 mW / cm 2 and the irradiation energy for 1 minute was 1.25 × 10 6 erg / cm 2 / min. Each cream was applied 30 minutes before UV irradiation.
(結果) 結果は表2に示す通りであった。
クリームを塗布しなかった場合のMEDは5.41×106erg/cm2で、クリーム塗布(比較例1)によりMEDはわずかに延長した。 When the cream was not applied, the MED was 5.41 × 10 6 erg / cm 2 , and the MED was slightly extended by applying the cream (Comparative Example 1).
比較例2のMEDは比較例1より大きく、バジル水抽出液を含むクリームはMEDを延長させた。 The MED of Comparative Example 2 was larger than that of Comparative Example 1, and the cream containing the basil water extract extended the MED.
ビタミンCとビタミンEを含むクリーム(比較例3)は、クリーム塗布(比較例1)よりMEDを延長させた。 The cream containing vitamin C and vitamin E (Comparative Example 3) has a longer MED than the cream application (Comparative Example 1).
それに併せてバジル水抽出液を加えたクリーム(実施例1)はMEDを飛躍的に延長させた。それに対して、併せてインドメサシンを加えたクリーム(比較例4)ではさらなる延長はみられなかった。 In addition, the cream (Example 1) to which the basil aqueous extract was added prolongs the MED dramatically. On the other hand, no further extension was observed in the cream added with indomethacin (Comparative Example 4).
パラメトキシケイヒ酸-2-エチルヘキシルを含むクリーム(比較例5)はMEDを延長させた。 A cream containing 2-methoxyhexyl paramethoxycinnamate (Comparative Example 5) extended the MED.
比較例5にさらにバジル水抽出液を加えたクリーム(実施例2)はMEDを大きく延長させた。 The cream (Example 2) obtained by further adding the basil water extract to Comparative Example 5 greatly extended the MED.
以上のように、バジル水抽出液を含むクリームには紫外線による紅斑形成を抑制する作用が認められた。さらに、抗酸化剤であるビタミンCとビタミンEあるいは紫外線吸収剤であるパラメトキシケイヒ酸-2-エチルヘキシルについても紫外線による紅斑形成を抑制する作用が認められた。また、ビタミンCとビタミンEに併せてバジル水抽出液を含ませたクリームでは紫外線による紅斑形成を抑制する作用が相乗的に増加することが認められた。しかし、ビタミンCとビタミンEに併せてインドメサシンを含ませたクリームでは紫外線による紅斑形成を抑制する作用の増加が認められなかった。これは、バジル水抽出液がビタミンCとビタミンEと併用することで特異的に作用し、相乗的に紫外線による紅斑形成を抑制する作用を有することを示唆している。 As described above, the cream containing the basil water extract was found to have an effect of suppressing erythema formation due to ultraviolet rays. In addition, vitamin C and vitamin E, which are antioxidants, and 2-ethylhexyl paramethoxycinnamate, which is an ultraviolet absorber, were also found to suppress the formation of erythema due to ultraviolet rays. In addition, creams containing basil water extract in combination with vitamin C and vitamin E were found to synergistically increase the effect of suppressing erythema formation due to ultraviolet rays. However, the cream containing indomethacin in combination with vitamin C and vitamin E did not increase the effect of suppressing erythema formation due to ultraviolet rays. This suggests that the basil water extract acts specifically when combined with vitamin C and vitamin E, and synergistically suppresses erythema formation due to ultraviolet rays.
本発明の日焼け止め皮膚外用剤は、皮膚安全性に優れ、しかも高い日焼け止め効果を有するため、広くサンスクリーン化粧料等へ応用が期待できる。 Since the sunscreen skin external preparation of the present invention is excellent in skin safety and has a high sunscreen effect, it can be widely applied to sunscreen cosmetics and the like.
Claims (3)
UV protective agent is cinnamic acid UV absorber, benzophenone UV absorber, benzoic acid UV absorber, salicylic acid UV absorber, dibenzoylmethane UV absorber, anthranilic acid UV absorber, urocanic acid UV 2. The skin external preparation according to claim 1, wherein the external preparation is one or more selected from an absorbent and an ultraviolet scattering agent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005259538A JP2007070291A (en) | 2005-09-07 | 2005-09-07 | Sunscreen external lotion |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005259538A JP2007070291A (en) | 2005-09-07 | 2005-09-07 | Sunscreen external lotion |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2007070291A true JP2007070291A (en) | 2007-03-22 |
Family
ID=37932053
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005259538A Pending JP2007070291A (en) | 2005-09-07 | 2005-09-07 | Sunscreen external lotion |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2007070291A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013523845A (en) * | 2010-04-12 | 2013-06-17 | パージェネシス・テクノロジーズ・インコーポレーテッド | Use of photosynthetic cell extracts containing functional thylakoids in cosmetic compositions |
CN104840542A (en) * | 2015-05-04 | 2015-08-19 | 刘长迎 | External lotion for curing ankle joint old tendon injury |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0624937A (en) * | 1992-06-29 | 1994-02-01 | Narisu Keshohin:Kk | Mucopolysaccharide fragmentation-inhibiting agent, active oxygen-scavenging agent, antioxidative agent and cosmetic |
JPH1077211A (en) * | 1996-09-05 | 1998-03-24 | Pola Chem Ind Inc | Cosmetic material for make-up |
JP2001097888A (en) * | 1999-09-28 | 2001-04-10 | Hiroshi Ikeno | Composition for external use |
JP2001335457A (en) * | 2000-05-26 | 2001-12-04 | Yakult Honsha Co Ltd | Antioxidant and skin care preparation containing the same |
JP2002047165A (en) * | 2000-08-01 | 2002-02-12 | Pola Chem Ind Inc | Cosmetic for sunburn prevention |
JP2002308724A (en) * | 2001-03-29 | 2002-10-23 | Council Scient Ind Res | Safe, eco-friendly, health rpotective herbal color and aroma useful for cosmaceutical application |
JP2003095915A (en) * | 2001-09-25 | 2003-04-03 | Shiseido Co Ltd | Skin care composition |
JP2005170858A (en) * | 2003-12-12 | 2005-06-30 | Noevir Co Ltd | Skin care preparation for external use |
JP2005170860A (en) * | 2003-12-12 | 2005-06-30 | Noevir Co Ltd | Skin care preparation for external use |
-
2005
- 2005-09-07 JP JP2005259538A patent/JP2007070291A/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0624937A (en) * | 1992-06-29 | 1994-02-01 | Narisu Keshohin:Kk | Mucopolysaccharide fragmentation-inhibiting agent, active oxygen-scavenging agent, antioxidative agent and cosmetic |
JPH1077211A (en) * | 1996-09-05 | 1998-03-24 | Pola Chem Ind Inc | Cosmetic material for make-up |
JP2001097888A (en) * | 1999-09-28 | 2001-04-10 | Hiroshi Ikeno | Composition for external use |
JP2001335457A (en) * | 2000-05-26 | 2001-12-04 | Yakult Honsha Co Ltd | Antioxidant and skin care preparation containing the same |
JP2002047165A (en) * | 2000-08-01 | 2002-02-12 | Pola Chem Ind Inc | Cosmetic for sunburn prevention |
JP2002308724A (en) * | 2001-03-29 | 2002-10-23 | Council Scient Ind Res | Safe, eco-friendly, health rpotective herbal color and aroma useful for cosmaceutical application |
JP2003095915A (en) * | 2001-09-25 | 2003-04-03 | Shiseido Co Ltd | Skin care composition |
JP2005170858A (en) * | 2003-12-12 | 2005-06-30 | Noevir Co Ltd | Skin care preparation for external use |
JP2005170860A (en) * | 2003-12-12 | 2005-06-30 | Noevir Co Ltd | Skin care preparation for external use |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013523845A (en) * | 2010-04-12 | 2013-06-17 | パージェネシス・テクノロジーズ・インコーポレーテッド | Use of photosynthetic cell extracts containing functional thylakoids in cosmetic compositions |
CN104840542A (en) * | 2015-05-04 | 2015-08-19 | 刘长迎 | External lotion for curing ankle joint old tendon injury |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010110020A1 (en) | Sunscreen cosmetic | |
US20210161779A1 (en) | Hand Sanitizing Compositions | |
CN104207964A (en) | Oil-in-water type sunscreen lotion | |
CN110840794B (en) | Blue-light-resistant and infrared-resistant sunscreen composition and application thereof | |
JP5540243B2 (en) | Sunscreen cosmetics | |
CA2863278C (en) | Composition and combination of bmdbm photostabilizers and sunscreens | |
JP2022551959A (en) | Water-resistant and/or photoprotective composition containing non-solubilized micronized wax | |
US20160008256A1 (en) | A photoprotective personal care composition | |
WO2022081942A1 (en) | Photoprotective cosmetic compositions comprising xanthommatin as an antioxidant and uv-filter stabilizer | |
JP2007070291A (en) | Sunscreen external lotion | |
Widiyati | Determination of ultraviolet filter activity on coconut oil cosmetic cream | |
JP6815093B2 (en) | Underwater oil type sunscreen cosmetics | |
US20210290510A1 (en) | COSMETIC COMPOSITION CONTAINING a-MANGOSTIN, METHOD FOR PREPARATION, AND USES THEREOF | |
DE202013001754U1 (en) | Sunscreen for use on wet skin | |
EP3644941B1 (en) | A phosphorus based sunscreen converting ultraviolet radiation to red wavelengths | |
EP2853255A1 (en) | Method of formulating a personal care product with substantially no whitening effect when applied on wet skin and compositions thereof | |
US20150093343A1 (en) | Method of formulating a personal care product with substantially no whitening effect when applied on wet skin and compositions thereof | |
JP6569304B2 (en) | Sunscreen composition | |
EP3122321B1 (en) | Photostable sunscreen composition for topical application | |
KR20210138673A (en) | Sunscreen composition comprising butyl methoxydibenzoylmethane, a triazine derivative and a light stabilizer | |
JP2006315957A (en) | Singlet oxygen scavenger and external preparation for skin using the same | |
Gupta et al. | Pharmacological review of chemical agents used in sunscreen preparations | |
AU2014101446A4 (en) | Sunscreen formulations | |
JP2013173681A (en) | Singlet oxygen eliminator | |
EP2431021A1 (en) | Sunscreen composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080905 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111025 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111226 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120306 |